News
BLIN Reports Results
Bridgeline Digital (NASDAQ:BLIN) reported fiscal third quarter 2025 results on August 14, 2025, highlighting $3.8 million in GAAP revenue, $3.1 million in GAAP subscription license revenue (81% of
Plus Therapeutics Posts Q2 Profit Jump
Plus Therapeutics (NASDAQ:PSTV), a clinical-stage biotech focused on radiotherapeutics and diagnostics for central nervous system cancers, reported its second quarter 2025 results on August 14
Xwell Posts 17% Revenue Drop in Q2
Xwell (NASDAQ:XWEL), best known for its airport wellness spas and health services, released its second quarter 2025 results on August 14, 2025. The release showed GAAP revenue of $7.7 million, down
Outlook Therapeutics Reports Q3 Revenue
Outlook Therapeutics (NASDAQ:OTLK), a biopharmaceutical company focused on ophthalmic treatments, released its third quarter fiscal 2025 results on August 14, 2025. The company posted its first-ever
Venus Concept Sells Venus Hair Unit
Venus Concept(NASDAQ:VERO) reported second quarter 2025 results on Aug. 14, 2025, highlighting $15.7 million in GAAP revenue for Q2 2025, down 5% year-over-year, a GAAP operating loss of $9 million
Dragonfly Energy Sales Jump 23 Percent
Dragonfly Energy (NASDAQ:DFLI), a Nevada-based energy storage technology company known for manufacturing lithium iron phosphate (LFP) batteries and integrated energy storage systems, released its
Stock Market Today: Intel Climbs as White House Mulls Strategic Stake in Chipmaker
Intel (NASDAQ: INTC) surged 7.4% on Thursday to close at $23.86, with trading volume roughly doubling its 3-month average. The rally followed reports that the Trump administration is in talks to
P3 Health (PIII) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Aug. 14, 2025 at 4:30 p.m. ET
Chief Executive Officer — Aric Coffman
Source Fool.com
Celcuity Q2 Results Highlight Cash Surge
Celcuity(NASDAQ:CELC) reported second quarter 2025 results on Aug. 14, 2025, highlighted by top-line Phase III data for gedatolisib in second-line HR-positive, HER2-negative advanced breast cancer
Dillard's Reports 1% Sales Rise in Q2
Dillard's (NYSE:DDS), the department store operator with a focus on exclusive merchandise and a broad retail footprint, reported its fiscal second quarter 2025 results on August 14, 2025. The
Why Weibo Stock Popped by Over 11% Today
One of China's largest and most important social media companies, Weibo (NASDAQ: WB), was a real hit with American investors on Thursday. The company's American Depositary Shares (ADSes) closed that
Celcuity (CELC) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 14, 2025 at 4:30 p.m. ET
Chief Executive Officer and Cofounder — Brian Sullivan
Source Fool.com
Annexon Narrows Loss in Fiscal Q2
Annexon (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing therapies for serious autoimmune and neurodegenerative diseases, released its second quarter 2025 financial results on
Origin Materials Sales Fall 17 Percent
Origin Materials (NASDAQ:ORGN), a sustainable materials developer aiming to transform the global packaging market, reported results on August 14, 2025. The big news: Origin delivered its first
Stock Market Today: TeraWulf Jumps on $3.7 Billion AI Deal and Google Partnership
TeraWulf (NASDAQ: WULF) soared 60% on Thursday to close at $8.71, driven by staggering volume -- over 286 million shares traded, more than six times its 3-month average. The jump followed news that
Talphera Cuts Costs and Speeds Trial
Talphera(NASDAQ:TLPH) reported second quarter 2025 results on August 14, 2025, highlighting accelerated clinical trial enrollment and a reduction in annual cash operating expense guidance to $16
Talphera TLPH Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Aug. 14, 2025 at 4:30 p.m. ET
Chief Executive Officer — Vincent Angotti
Source Fool.com
Tyra Biosciences Narrows Loss in Q2
Tyra Biosciences (NASDAQ:TYRA), a clinical-stage biotech company focused on therapies for FGFR (fibroblast growth factor receptor) conditions, released its second quarter results on August 14, 2025
bioAffinity Misses Q2 Revenue Target
bioAffinity Technologies (NASDAQ:BIAF), a biotechnology company focused on noninvasive diagnostics and cancer therapeutics, reported results for Q2 2025 on August 14, 2025. The most significant news
Sandisk Reports 8 Percent Revenue Gain
Sandisk (NASDAQ:SNDK), a leading provider of flash memory and storage solutions, released its quarterly results on August 14, 2025. The company reported GAAP revenue of $1.90 billion, surpassing its
Genasys Backlog Hits 61 Million in Q3
Genasys (NASDAQ:GNSS) reported fiscal 3Q2025 results on August 14, 2025, with revenues rising 38% year over year to $9.9 million (GAAP) on strong contributions from Puerto Rico. Hardware sales drove
Reading Revenue Jumps 29% in Fiscal Q2
Reading International (NASDAQ:RDI), an operator of cinemas and real estate properties across the United States, Australia, and New Zealand, reported its second quarter fiscal 2025 results on August
Unusual Machines Sales Jump 51%
Unusual Machines (NYSEMKT:UMAC), a U.S.-based drone technology company best known for its ultra-low latency video goggles and enterprise drone solutions, reported its Q2 2025 earnings on Aug. 14
Co-Diagnostics CODX Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 14, 2025 at 4:30 p.m. ET
Chief Executive Officer — Dwight Egan
Source Fool.com
P3 Health Partners Posts Q2 Revenue Drop
P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable